Related Experiment Video
Updated: Aug 4, 2025

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
Predicting peritoneal recurrence in gastric cancer with serosal invasion using a pathomics nomogram
Dexin Chen1, Jianbo Lai1, Jiaxin Cheng1
1Department of General Surgery, Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, The First School of Clinical Medicine, Southern Medical University, Guangzhou 510515, P.R. China.
A new pathomics signature can predict peritoneal recurrence in gastric cancer (GC) with serosal invasion. This signature, combined with clinical factors, forms a nomogram to assess individual patient risk for this lethal recurrence pattern.
Area of Science:
- Oncology
- Digital Pathology
- Biomarker Discovery
Background:
- Peritoneal recurrence is a major challenge in gastric cancer (GC) with serosal invasion.
- Current methods inadequately predict peritoneal recurrence risk in these patients.
- Pathomics analysis shows promise for improved risk stratification.
Purpose of the Study:
- To develop and validate a pathomics signature for predicting peritoneal recurrence in GC.
- To create a nomogram integrating pathomics and clinical factors for personalized risk assessment.
Main Methods:
- Extraction of pathomics features from digital hematoxylin and eosin-stained GC images.
- Development of a pathomics signature based on identified features.
- Construction of a competing-risk pathomics nomogram incorporating clinical variables and the pathomics signature.
Main Results:
- The pathomics signature was significantly associated with peritoneal recurrence.
- The developed pathomics nomogram demonstrated favorable discrimination and calibration.
- The nomogram effectively integrated pathomics and clinical data for risk prediction.
Conclusions:
- A novel pathomics signature serves as a valuable predictive indicator for peritoneal recurrence in GC.
- The pathomics nomogram offers a reliable tool for assessing individual risk of peritoneal recurrence in serosal-invasive GC.
More Related Videos
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024